Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abcellera, Algernon, Aribio, Aslan, Biophytis, Bio-Thera Solutions, Brickell, Cardiol, Debiopharm, Dynavax, Eli Lilly, Grifols, Immutep, Jemincare, Kaken, Medigen Vaccine, Moderna, Senhwa, Sinomab, Synairgen, Zydus Cadila.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Alexion, Ampio, Atyr, Caladrius, Celltrion, Cyxone, Gannex, Glaxosmithkline, Glow Lifetech, Helsinn Healthcare, Kyorin, MGC, Relay Medical, Rockwell Medical, Senhwa, Shanghai Fosun, Sorrento, Swiss, Synairgen, Taiho, Verona, Vir.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: AM, Arch Biopartners, Aslan, Atyr, Basilea, Cerecor, Codagenix, Creative Medical Technology, Dalcor, Dr. Reddy’s, Edesa, Immutep, Kintor, Mesoblast, Neurorx, Quantum Leap Healthcare, Relief, Russian Direct Investment Fund, Sanbio, Serum Institute of India, Windtree.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Arcturus, Direct Biologics, Emergent Biosolutions, Kaleido, Neurorx, Nicox, Ocumension, Redhill, Regeneron, Relief, Sinopharm, Tiziana Life Sciences.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acticor, Aim Immunotech, Algernon, Apogenix, Ascentage, Astellas, Biocryst, Curevac, Dynavax, Gannex, Inovio, Kiniksa, Mitsubishi Tanabe, Novavax, Redhill, Revive, Serum Institute of India, Taiwan Liposome, Unity, Vicore.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abpro, Aldeyra, Algernon, Ampio, Arca, Boehringer Ingelheim, Brii, Calcimedica, Cytodyn, Eusa, FSD, Glaxosmithkline, Hightide, Inotrem, Medincell, Mesoblast, Molecular, Ology, Regeneron, Taiwan Liposome, Valneva, Vasomune, Vir.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Abivax, Advaccine, Amarin, Astrazeneca, Biontech, Curevac, Daiichi Sankyo, Eli Lilly, EOC, Immutep, Incyte, Innovent, Inovio, Junshi, Kazia, Kintor, Mitsubishi Tanabe, Moderna, Novartis, Pfizer, Pharming, Tychan, Vicore.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Ampio, Apeiron, Appili, Ascletis, Astrazeneca, Beigene, Celularity, Dr. Reddy’s, Enlivex, Inovio, Junshi, Neurorx, Puretech Health, Relief, Senhwa, Sichuan Clover, Takeda, Therapeutics Solution, Zymeworks. Extra

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Aim Immunotech, Algernon, Ascentage, Biocryst, Capricor, Celltrion, Curevac, Edesa, Equillium, Imago, Marinomed, Moderna, Neoimmunetech, Novavax, Reithera.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: 3Sbio, Amarin, Ampio, Astrazeneca, Beigene, Bellerophon, Biolinerx, Biontech, Bioshin, Boehringer Ingelheim, CASI, Clear Creek, Cytodyn, Edding, Eisai, Gannex, Gemvax & Kael, Helixmith, Idorsia, Immutep, Imugene, Innovent, Kangpu, Kazia, Marinomed, Merck, Molecular Partners, Mydecine Innovations, Organicell Regenerative Medicine, Pfizer, Redhill, Sagimet, Selecta, Trippbio.